Factor IX(a) inhibitors: an updated patent review (2003-present).

Afosah, Daniel K; Ofori, Edward; Mottamal, Madhusoodanan; Al-Horani, Rami A

Afosah, Daniel K; Ofori, Edward; Mottamal, Madhusoodanan; Al-Horani, Rami A.

Afiliación

Afosah DK; Department of Chemistry and Biochemistry, Washington and Lee University, Lexington, VA, USA.
Ofori E; Department of Pharmaceutical Sciences, College of Pharmacy, Chicago State University, Chicago, IL, USA.
Mottamal M; Department of Chemistry, College of Arts and Sciences, Xavier University of Louisiana, New Orleans, LA, USA.
Al-Horani RA; Division of Basic Pharmaceutical Sciences, College of Pharmacy, Xavier University of Louisiana, New Orleans, Louisiana, USA.

Expert Opin Ther Pat ; 32(4): 381-400, 2022 Apr.

Article en En | MEDLINE | ID: mdl-34991418

Asunto(s)

Factor IX; Trombosis; Animales; Anticoagulantes/efectos adversos; Factor IX/uso terapéutico; Hemorragia/inducido químicamente; Humanos; Patentes como Asunto; Trombosis/tratamiento farmacológico

Palabras clave

Factor ix(a); anticoagulants; aptamers; monoclonal antibodies; small molecules

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trombosis / Factor IX Límite: Animals / Humans Idioma: En Revista: Expert Opin Ther Pat Asunto de la revista: TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google